Psyched Wellness Is Pleased to Announce Recent Neurobehavioral Study Evaluating Efficacy and Safety of AME-1
Toronto, Ontario--(Newsfile Corp. – March 28, 2023) - Psyched Wellness Ltd. (CSE: PSYC) (OTC Pink: PSYCF) (the "Company" or "Psyched"), a life sciences company focused on the production and distribution of artisanal functional mushrooms, is pleased to announce the company KGK, a licensed CRO in Canada, has completed the last study on the safety and efficacy of AME-1 extract. The result of the study shows that AME-1 alone or in combination with ethanol did not impair any learning or memory state, motor coordination, balance or altered behavioral activity. The neurobehavioral study was to evaluate the efficacy and safety of Amanita muscaria extract (AME-1) alone, and in combination with ethanol, in a behavioral test battery including the Morris water maze (MWM), accelerating rotarod (RR) test, balance beam (BB) and forced swim tests (FST). All of these tests are designed to look at behavioral despair, memory and learning, motor coordination, and maintaining balance.
The importance of this study in conjunction with the other toxicity studies is to provide scientific evidence for the efficacy and safety of AME-1. This study further understands the effects of Amanita Muscaria extract (AME-1) under a scientific methodology which reinforces a safe dose for human consumption.
“This milestone event further provides information in the toxicological assessment of AME-1. The results of this study further increases the knowledge in a scientific setting indicating no negative behavioral and neurological functional changes with the use of AME-1.” says Brian Tancowny, a scientific advisor for Psyched Wellness.
Visit https://shop.psyched-wellness.com/ for more information about ordering the product directly.